Related Experiment Videos
Clinical manifestations, management and therapy of HIV infection in children
Insights
Perinatal HIV infection in children can occur during pregnancy, birth, or breastfeeding. Early diagnosis and antiviral therapy significantly improve outcomes for pediatric HIV, requiring comprehensive family-centered care.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Perinatal HIV infection is a primary cause of pediatric HIV globally.
- Transmission routes include in utero, intrapartum, and postpartum via breastfeeding.
- The exact risk of HIV transmission through breastfeeding remains undetermined.
Purpose of the Study:
- To summarize the transmission, clinical presentation, and management of HIV in children.
- To highlight advancements in diagnosis and antiviral therapy for pediatric HIV.
- To emphasize the need for comprehensive, family-oriented care for improved quality of life.
Main Methods:
- Review of existing literature on pediatric HIV transmission and management.
- Analysis of clinical findings and diagnostic criteria for HIV in infants.
- Evaluation of current and emerging antiviral treatment strategies.
Main Results:
- HIV transmission occurs via multiple perinatal routes, with breastfeeding being a significant factor, especially with recent maternal infection.
- Infants with HIV often exhibit early clinical symptoms, including opportunistic infections and multi-organ involvement.
- Early diagnosis and antiviral therapy, alongside supportive care, have improved prognosis and survival rates.
Conclusions:
- Pediatric HIV management requires vigilant monitoring, prompt treatment of infections, and prophylactic measures.
- Antiviral therapies like zidovudine and didanosine are crucial, with ongoing research into new drugs.
- A holistic, family-centered approach is essential for enhancing the quality of life and prolonging survival for children with HIV.
Abstract:
Perinatal infection accounts for the majority of cases of HIV infection in children both in developed and developing countries. Transmission may occur in utero, intrapartum or postpartum as a result of breast-feeding. The actual risk of transmission through breast-feeding is unknown. The majority of infants reported to be infected through breast milk have been infected as a result of a recently acquired HIV infection in the mother. Infants with HIV infection frequently present with clinical symptoms early in life. There is a broad spectrum of clinical findings in paediatric HIV infection, with opportunistic infections and multiorgan system involvement being common. The management of infants born to seropositive mothers includes routine paediatric care as well as careful clinical and laboratory monitoring for evidence of HIV infection. Infants who are seronegative with normal clinical and immunological findings at 18 months of age are considered uninfected. The prognosis and outcome of infants with HIV infection have improved considerably with earlier diagnosis and the availability of specific antiviral therapy. Modalities of therapy include frequent medical evaluation, aggressive diagnosis and treatment of infection, prophylaxis for Pneumocystis carinii infection, the use of intravenous gamma-globulin and specific antiviral therapy, such as zidovudine, didanosine or other drugs in development through clinical trials. HIV infection in children is a chronic illness and requires a comprehensive, family-oriented approach to care. With longer survival, children require support systems and an atmosphere of care and understanding to give them a good quality of life as well as prolonged survival.